Shelley N Facente Selected Research

Shelley N Facente Research Topics

6	Infections 01/2023 - 01/2017
4	HIV Infections (HIV Infection) 01/2019 - 01/2011
2	COVID-19 01/2022 - 12/2021
1	Sepsis (Septicemia) 12/2021
1	Clinical Deterioration 12/2021
1	Breakthrough Infections 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2018
1	HIV Seropositivity 12/2016

3	AntigensIBA 01/2019 - 12/2017
2	AntibodiesIBA 01/2023 - 12/2016
2	Fluvoxamine (Luvox)FDA LinkGeneric 01/2022 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2016
2	RNA (Ribonucleic Acid)IBA 01/2017 - 01/2011
1	Hepatitis C AntibodiesIBA 01/2022
1	VaccinesIBA 01/2022
1	Sigma-1 ReceptorIBA 12/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2021
1	CytokinesIBA 12/2021
1	AIDS VaccinesIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	HIV AntibodiesIBA 01/2017

1	Therapeutics 01/2017